As of Nov 2020 ยท from Provenance 1 ยท a SAFE/note conversion ceiling, not a priced valuation
Total raised
$369,546
Across 2 rounds since 2019
Latest share price
$1.00
Reg CF Offering (2019) offering price
Financials
FY2017โFY2023 ยท from SEC filings ยท hover any figure for its source
$1.0M
$122K
2017
$1.4M
$76K
2018
$1.3M
$3K
2020
$2.7M
$139K
2021
$1.2M
โ$260K
2022
$1.4M
โ$91K
2023
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$1,037,732
$1,430,801
$1,273,129
$2,729,502
$1,245,213
$1,424,439
Cost of goods sold
$422,818
$549,180
$434,927
$1,094,348
$582,214
$564,905
Gross margin
59%
62%
66%
60%
53%
60%
Net income
$122,393
$76,030
$2,894
$139,349
-$260,018
-$90,985
Taxes paid
$0
$0
$0
$121,408
$0
$0
Balance sheet
Cash
$66,345
$35,204
$28,925
$277,927
$293,816
$239,698
Accounts receivable
$0
$0
-$3,500
$0
$1,394
$1,162
Total assets
$120,505
$105,026
$204,937
$497,165
$361,928
$238,853
Short-term debt
$69,190
$95,026
$104,418
$175,139
$65,359
$155,113
Long-term debt
$21,148
$10,000
$97,625
$199,767
$536,187
$521,561
Total liabilities
$90,338
$105,026
$202,043
$374,906
$601,546
$676,674
Other
Headcount
โ
8
โ
30
30
0
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.